Intellia Therapeutics (NTLA) EBIT Margin Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,211.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,993.00 |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - | 22,006.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,006.00 |
| Dec 31, 2025 | 38,222.00 |
| Sep 30, 2025 | -1,337.00 |
| Jun 30, 2025 | -7,152.00 |
| Mar 31, 2025 | 55,539.00 |
| Dec 31, 2024 | -43,426.00 |
| Sep 30, 2024 | 2.24 Mn |
| Jun 30, 2024 | -94,491.00 |
| Mar 31, 2024 | 32,633.00 |
| Dec 31, 2023 | 794,034.00 |
| Sep 30, 2023 | -96,682.00 |
| Jun 30, 2023 | -77,035.00 |
| Mar 31, 2023 | -22,717.00 |
| Dec 31, 2022 | -53,884.00 |
| Sep 30, 2022 | -55,691.00 |
| Jun 30, 2022 | -45,366.00 |
| Mar 31, 2022 | -105,375.00 |
| Dec 31, 2021 | -36,233.00 |
| Sep 30, 2021 | -2.37 Mn |
| Jun 30, 2021 | -74,635.00 |
| Mar 31, 2021 | -42,002.00 |
| Dec 31, 2020 | -27,225.00 |
| Sep 30, 2020 | 9,049.00 |
| Jun 30, 2020 | 6,757.00 |
| Mar 31, 2020 | -45,263.00 |
| Dec 31, 2019 | -7,991.00 |
| Sep 30, 2019 | -8,050.00 |
| Jun 30, 2019 | -8,184.00 |
| Mar 31, 2019 | 14,849.00 |
| Dec 31, 2018 | 6,106.00 |
| Sep 30, 2018 | -12,975.00 |
| Jun 30, 2018 | -5,884.00 |
| Mar 31, 2018 | -20,738.00 |